YOKNEAM, ISRAEL--(Marketwire - May 14, 2012) - Syneron Medical Ltd. (NASDAQ: [ ELOS ]), [ www.syneron.com ], the global leader in medical aesthetic products and technology, announced today recognition in the Essence Best in Black Beauty Awards 2012 for their elure™ Advanced Lightening Night Cream in the skincare category. This follows on the heels of elure being chosen for a Best of Beauty award in the Big Breakthrough category for 2011 by allure magazine.

With only nine skin care solutions earning a coveted place among the best of beauty, 2012 marks the inaugural year of the Best in Black Beauty Awards from Essence magazine. "We are immensely honored to receive this prestigious award from Essence magazine, a publication for which we have the utmost regard," said Louis P. Scafuri, Chief Executive Officer of Syneron. "elure reflects our long term commitment to developing innovative aesthetic applications for the face and body that are gentle yet clinically effective for all skin types. This honor puts us at the forefront of exciting technological advancements that aim to exceed the highest standards of our partners around the world."

Traditionally most skin lighteners, including hydroquinone, were only able to address dark spots by blocking the production of melanin deep within the skin. For years, researchers have been searching for an ingredient that could break down hyperpigmentation on the skin's surface, without compromising skin health or color -- and the creators of elure have done exactly that. Dr. Shimon Eckhouse, Chairman of the Board of Syneron, commented, "elure is a prime example of Syneron's continued dedication to advancing our field with innovative solutions that address the diverse needs of our customers. Due to its outstanding efficacy and safety profile, elure has rapidly become the physician's choice for skin lightening. Now this is further validated by leading beauty experts through this recognition."

"As a non-hydroquinone lightening solution, elure Advanced Skin Lightening products are effective on all skin types and work to safely and gently even out skin tone on all skin types including the most sensitive skin with noticeable outcomes in one to two months," states Jeanine Downie, M.D., board certified Dermatologist and founder of Image Dermatology in Montclair, New Jersey.

elure™ Advanced Skin Lightening Night Cream is featured in the May 2012 issue of Essence magazine, with a circulation over 1 million readers. The list can also be viewed on Essence.com: [ http://photos.essence.com/galleries/best_in_black_beauty__skin#1233693 ]

For more information about elure Advanced Skin Lightening products visit [ www.elureskin.com ] or follow us on Facebook: [ http://www.facebook.com/elureskin ].

About Syneron Medical Ltd.

Syneron Medical Ltd. -- a company devoted to real technology, real science and real results -- is the leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela. With its innovative approach to aesthetic treatments, Syneron has now entered into one of the largest in-demand applications, skin lightening. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the US. The company markets and services and supports its products in 86 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.

About elure™ Advanced Skin Lightening products

elure™ is sold as a topical cosmetic intended to beautify your skin and cosmetics are not subject to evaluation by the FDA. All product information provided is intended to be for informational purposes only. The information about skin conditions provided herein does not constitute medical or pharmaceutical advice and should not be relied upon as a substitute for qualified medical consultation with health professionals.

Additional information can be found at [ www.syneron.com ].